Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Bone Erosion Healing in Rheumatoid Arthritis
NCT03239080Phase 2Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jun 2017
- Primary completion
- May 2020
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in rheumatoid arthritis (RA), sponsored by The Chinese University of Hong Kong. Started Jun 2017; status: completed.
02
Drugs
denosumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03239080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03239080.